Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

NCT01827540 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV-infection/AIDS

Interventions

DRUG: Cenicriviroc
DRUG: Dolutegravir
DRUG: Midazolam

Sponsor

Tobira Therapeutics, Inc.

Collaborators

[object Object]